This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

OnCure Holdings, Inc. And Certain Affiliates File Petitions Under Chapter 11

ENGLEWOOD, Colo., June 14, 2013 /PRNewswire/ -- OnCure Holdings, Inc. and certain of its affiliates, leading providers of management services and facilities to oncology physician groups throughout the country, filed voluntary petitions to commence proceedings under Chapter 11 of the United States Bankruptcy Code in an effort to restructure their finances.  The petitions were filed in the United States Bankruptcy Court for the District of Delaware.

Prior to filing, OnCure, in consultation with an ad hoc group of secured noteholders, engaged in an extensive campaign to market the company's assets to potential financial and strategic buyers, resulting in an agreement in principle regarding a proposed acquisition with a third-party purchaser for aggregate consideration of approximately $125 million (and with reimbursement of certain expenses, of approximately $126.5 million).  The transaction remains subject to the negotiation and execution of definitive documentation by the parties. 

OnCure's legal advisors in connection with its restructuring are Latham & Watkins LLP and Richards, Layton & Finger, P.A.  Financial advisory services are being provided by Jefferies LLC. Match Point Partners LLC is providing management services to OnCure.

For more information on OnCure, please visit .  For more information on OnCure's bankruptcy case, please visit , email , or call the case-dedicated toll-free phone number at (877) 634-7166.

SOURCE OnCure Holdings, Inc.
Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,888.35 +168.43 0.95%
S&P 500 2,102.63 +22.22 1.07%
NASDAQ 5,156.3060 +47.64 0.93%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs